Based on a similar comparison of CD1d−/− and Jα18−/− mice, type II NKT cells were also implicated in the suppression of antitumor response responsible for controlling the growth of implanted CT26 colon carcinoma and inhibiting the development of pulmonary metastases following intravenous injection of tumor cells [78–80]. This evidence concerns the gene CD1D and neoplasm.